Astrocyte control of synaptic transmission and neurovascular coupling

被引:944
作者
Haydon, Philip G. [1 ]
Carmignoto, Giorgio
机构
[1] Univ Penn, Sch Med, Dept Neurosci, Silvio Conte Ctr Integrat Tripartite Synapse, Philadelphia, PA 19104 USA
[2] Univ Padua, Ist Neurosci, Ctr Nazl Ric, Padua, Italy
[3] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy
关键词
D O I
10.1152/physrev.00049.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
From a structural perspective, the predominant glial cell of the central nervous system, the astrocyte, is positioned to regulate synaptic transmission and neurovascular coupling: the processes of one astrocyte contact tens of thousands of synapses, while other processes of the same cell form endfeet on capillaries and arterioles. The application of subcellular imaging of Ca2+ signaling to astrocytes now provides functional data to support this structural notion. Astrocytes express receptors for many neurotransmitters, and their activation leads to oscillations in internal Ca2+. These oscillations induce the accumulation of arachidonic acid and the release of the chemical transmitters glutamate, D-serine, and ATP. Ca2+ oscillations in astrocytic endfeet can control cerebral microcirculation through the arachidonic acid metabolites prostaglandin E-2 and epoxyeicosatrienoic acids that induce arteriole dilation, and 20-HETE that induces arteriole constriction. In addition to actions on the vasculature, the release of chemical transmitters from astrocytes regulates neuronal function. Astrocyte-derived glutamate, which preferentially acts on extrasynaptic receptors, can promote neuronal synchrony, enhance neuronal excitability, and modulate synaptic transmission. Astrocyte-derived D-serine, by acting on the glycine-binding site of the N-methyl-D-aspartate receptor, can modulate synaptic plasticity. Astrocyte-derived ATP, which is hydrolyzed to adenosine in the extracellular space, has inhibitory actions and mediates synaptic cross-talk underlying heterosynaptic depression. Now that we appreciate this range of actions of astrocytic signaling, some of the immediate challenges are to determine how the astrocyte regulates neuronal integration and how both excitatory (glutamate) and inhibitory signals (adenosine) provided by the same glial cell act in concert to regulate neuronal function.
引用
收藏
页码:1009 / 1031
页数:23
相关论文
共 247 条
  • [61] CALCIUM WAVES IN ASTROCYTES FILLING IN THE GAPS
    FINKBEINER, S
    [J]. NEURON, 1992, 8 (06) : 1101 - 1108
  • [62] FOLKOW B, 1989, J HYPERTENS, V7, pS1
  • [63] Three modes of synaptic vesicular recycling revealed by single-vesicle imaging
    Gandhi, SP
    Stevens, CF
    [J]. NATURE, 2003, 423 (6940) : 607 - 613
  • [64] Production of 20-HETE and its role in autoregulation of cerebral blood flow
    Gebremedhin, D
    Lange, AR
    Lowry, TF
    Taheri, MR
    Birks, EK
    Hudetz, AG
    Narayanan, J
    Falck, JR
    Okamoto, H
    Roman, RJ
    Nithipatikom, K
    Campbell, WB
    Harder, DR
    [J]. CIRCULATION RESEARCH, 2000, 87 (01) : 60 - 65
  • [65] MECHANISM OF ACTION OF CEREBRAL EPOXYEICOSATRIENOIC ACIDS ON CEREBRAL ARTERIAL SMOOTH-MUSCLE
    GEBREMEDHIN, D
    MA, YH
    FALCK, JR
    ROMAN, RJ
    VANROLLINS, M
    HARDER, DR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (02): : H519 - H525
  • [66] Golgi C., 1885, RIV SPER FREMIAT MED, V11, P72
  • [67] Beyond the gap: Functions of unpaired connexon channels
    Goodenough, DA
    Paul, DL
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (04) : 285 - 294
  • [68] Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy
    Gordon, GRJ
    Baimoukhametova, DV
    Hewitt, SA
    Rajapaksha, WRAKJS
    Fisher, TE
    Bains, JS
    [J]. NATURE NEUROSCIENCE, 2005, 8 (08) : 1078 - 1086
  • [69] Studying gene function in eukaryotes by conditional gene inactivation
    Gossen, M
    Bujard, H
    [J]. ANNUAL REVIEW OF GENETICS, 2002, 36 : 153 - 173
  • [70] Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?
    Griffith, TM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (06) : 881 - 903